$6.60
0.48[7.84%]
Last update: 4:26PM Get Real Time Here
ESSA Pharma
(NASDAQ:EPIX)ESSA Pharma Stock (NASDAQ:EPIX), Analyst Ratings, Price Targets, Predictions
ESSA Pharma Inc has a consensus price target of $18.5, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Oppenheimer, and Oppenheimer on December 13, 2023, August 9, 2023, and June 26, 2023. With an average price target of $17 between Oppenheimer, Oppenheimer, and Oppenheimer, there's an implied 157.58% upside for ESSA Pharma Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for ESSA Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/13/2023 | EPIX | Buy Now | ESSA Pharma | $6.60 | 157.58% | Oppenheimer | Mark Breidenbach | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | EPIX | Buy Now | ESSA Pharma | $6.60 | 157.58% | Oppenheimer | Mark Breidenbach | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 06/26/2023 | EPIX | Buy Now | ESSA Pharma | $6.60 | 157.58% | Oppenheimer | Mark Breidenbach | → $17 | Assumes | → Outperform | Get Alert |
| 05/12/2022 | EPIX | Buy Now | ESSA Pharma | $6.60 | 203.03% | Piper Sandler | Joseph Catanzaro | $50 → $20 | Maintains | Overweight | Get Alert |
| 08/17/2021 | EPIX | Buy Now | ESSA Pharma | $6.60 | 233.33% | Oppenheimer | Mark Breidenbach | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for ESSA Pharma (EPIX)?
The latest price target for ESSA Pharma (NASDAQ: EPIX) was reported by Oppenheimer on December 13, 2023. The analyst firm set a price target for $17.00 expecting EPIX to rise to within 12 months (a possible 157.58% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ESSA Pharma (EPIX)?
The latest analyst rating for ESSA Pharma (NASDAQ: EPIX) was provided by Oppenheimer, and ESSA Pharma reiterated their outperform rating.
When was the last upgrade for ESSA Pharma (EPIX)?
There is no last upgrade for ESSA Pharma.
When was the last downgrade for ESSA Pharma (EPIX)?
There is no last downgrade for ESSA Pharma.
When is the next analyst rating going to be posted or updated for ESSA Pharma (EPIX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ESSA Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ESSA Pharma was filed on December 13, 2023 so you should expect the next rating to be made available sometime around December 13, 2024.
Is the Analyst Rating ESSA Pharma (EPIX) correct?
While ratings are subjective and will change, the latest ESSA Pharma (EPIX) rating was a reiterated with a price target of $0.00 to $17.00. The current price ESSA Pharma (EPIX) is trading at is $6.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.